福泰瑞控股

US · FTRE #2796 按市值排名上市于 2023

22.49 -0.26 -1.12%

实时 - 追踪5344个代码 - 心跳于5秒前 · 2026-10-16 19:30

✦ 量化股权信号计算方式说明

增持

最近一期（2026/Q3）披露持股的机构数量增加了3家。
机构持股总比例上升了0.1个百分点。

机构持股

机构持股比例: 106.66% +0.12pp
机构数量: 388 +3
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund70.96%

Hedge Fund21.21%

Public Company11.47%

Government Pension Fund1.48%

Individual/Insider1.14%

Private Company0.76%

Insurance Company0.59%

主要股东截至 2026-06-30

BlackRock 16.61% · 15.80M 股

The Goldman Sachs Group, Inc. 8.71% · 8.28M 股

Vanguard Capital Management, LLC 5.06% · 4.81M 股

Sessa Capital IM, L.P. 4.83% · 4.59M 股

Vanguard Portfolio Management, LLC 4.01% · 3.82M 股

State Street Global Advisors 3.98% · 3.78M 股

FMR 3.83% · 3.65M 股

Corvex Management LP 3.14% · 2.99M 股

AQR Capital Management 3.02% · 2.87M 股

Geode Capital Management, LLC 2.68% · 2.55M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 23次买入 · 24次卖出

姓名	职务	持股比例
Peter Neupert	Independent Director	0.26%
Anshul Thakral	Chief Executive Officer	0.22%
Thomas Pike	Chief Executive Officer	0.17%
Mark Morais	COO & President of Clinical Services	0.09%
Jill McConnell	Chief Financial Officer	0.08%
Erin Russell	Independent Director	0.08%
Edward Pesicka	Independent Director	0.06%
Amrit Ray	Independent Director	0.06%
David Smith	Independent Director	0.04%
A. Sanders	Director	0.04%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-09-10	Jill McConnell	Chief Financial Officer	Intent to Sell (Form 144)	-1,032	$17.14
2026-09-09	Jill McConnell	Chief Financial Officer	Intent to Sell (Form 144)	-1,071	$16.53
2026-09-09	Jason Knoblauch	Chief Financial Officer	Other Derivative Acquisition	+144,434	--
2026-09-08	Jill McConnell	Chief Financial Officer	Intent to Sell (Form 144)	-1,051	$16.85
2026-09-08	Mark Morais	COO & President of Clinical Services	Derivative Exercise and Sale	-3,149	$16.85
2026-09-08	Mark Morais	COO & President of Clinical Services	Intent to Sell (Form 144)	-3,149	$16.85
2026-09-08	Carrie Russell	VP of Accounting & Interim Chief Accounting Officer	Derivative Exercise and Sale	-246	$16.85
2026-09-08	Carrie Russell	VP of Accounting & Interim Chief Accounting Officer	Intent to Sell (Form 144)	-246	$16.85
2026-09-07	Mark Morais	COO & President of Clinical Services	Derivative Exercise and Retained	+4,008	--
2026-09-07	Carrie Russell	VP of Accounting & Interim Chief Accounting Officer	Derivative Exercise and Retained	+604	--
2026-08-18	Jill McConnell	Chief Financial Officer	Intent to Sell (Form 144)	-4,892	$18.19
2026-08-18	Mark Morais	COO & President of Clinical Services	Derivative Exercise and Sale	-4,892	$18.19
2026-08-18	Mark Morais	COO & President of Clinical Services	Intent to Sell (Form 144)	-4,892	$18.19
2026-08-17	Mark Morais	COO & President of Clinical Services	Derivative Exercise and Retained	+6,421	--
2026-08-06	Carrie Russell	VP of Accounting & Interim Chief Accounting Officer	Initial Statement of Beneficial	0	--
2026-08-05	Anshul Thakral	Chief Executive Officer	Open Market Disposition	-111,857	$18.06–18.17
2026-08-04	Anshul Thakral	Chief Executive Officer	Derivative Exercise and Sale	-99,869	$19.03–19.28
2026-08-04	Anshul Thakral	Chief Executive Officer	Intent to Sell (Form 144)	-99,869	$19.16
2026-08-03	Anshul Thakral	Chief Executive Officer	Derivative Exercise and Retained	+316,797	--
2026-08-02	David Smith	Independent Director	Other Derivative Acquisition	+15,840	--

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。